| Lapatinib |
EU/1/07/440/005 |
TYVERB, Film coated tablet, 250, mg, Pack: 140 |
Glaxo Group Ltd., Обединено Кралство |
Glaxo Operations UK Ltd., UK; Glaxo Wellcome S.A., Spain |
3967.6 |
793.52 |
4761.12 |
4% |
10 |
3977.6 |
795.52 |
4773.12 |
16% |
25 |
4002.6 |
800.52 |
4803.12 |
промяна в обстоятелства НСР-5132/27.11.2014 |
КЦ-2824/04.10.2011 |
18.10.2011 |
18.10.2011 |
Неактивен |
3392 |
| Omeprazole |
II-13748/07.07.2006 |
Ulcoprol, Powder for solution for infusion, 40, mg, Pack: 5 |
Актавис EАД, България |
Балканфарма - Разград АД, България; Sofarimex-Ind. Quimica e Farmaceutica, Lda - Portugal |
33.78 |
6.76 |
40.54 |
4% |
1.35 |
35.13 |
7.03 |
42.16 |
16% |
5.4 |
40.53 |
8.11 |
48.64 |
|
КЦ-507/06.02.2009 |
19.02.2009 |
19.02.2009 |
Активен |
492 |
| Omeprazole |
16197/06,04,2007 |
Ulcoprol, Gastro resistant capsule, hard, 20, mg, Pack: 30 |
Актавис EАД, България |
Балканфарма- Дупница АД |
6.88 |
1.38 |
8.26 |
7% |
0.48 |
7.36 |
1.47 |
8.83 |
20% |
1.38 |
8.74 |
1.75 |
10.49 |
Цената се вписва в регистъра на пределните цени с решение НСР-2153/14.12.2013 |
КЦ-279/14.11.2008 |
11.12.2008 |
11.12.2008 |
Заличен |
245 |
| Indacaterol and glycopyrronium bromide |
EU/1/13/862/003 |
Ultibro Breezhaler, Inhalation powder, hard capsule, 85 mcg /43 mcg, -, Pack: 30 x 1 capsules (unit dose) + 1 inhaler |
Novartis Europharm Limited, Обединено Кралство |
Novartis Pharma GmbH, Германия |
89.77 |
17.95 |
107.72 |
4% |
3.59 |
93.36 |
18.67 |
112.03 |
16% |
14.36 |
107.72 |
21.54 |
129.26 |
корекц. НСР-6456/18.06.2015 |
НСР-6138/29.04.2015. |
14.05.2015 |
14.05.2015 |
Активен |
3857 |
| Indacaterol and glycopyrronium bromide |
EU/1/13/862 |
Ultibro Breezhaler, Inhalation powder, hard capsule, 85 mcg/ 43 mcg, UD, Pack: 30 |
Novartis Europharm Limited, Обединено Кралство |
Novartis Pharma GmbH, Германия |
96.15 |
19.23 |
115.38 |
4% |
3.85 |
100 |
20 |
120 |
16% |
15.38 |
115.38 |
23.08 |
138.46 |
|
НСР-4636/15.09.2014 |
30.09.2014 |
30.09.2014 |
Неактивен |
3857 |
| Iopromide |
15104/06,12,2006 |
Ultravist, Solution for injection/infusion, 370mg/ml-500 ml, mg, Pack: 8 |
Bayer Pharma AG, Германия |
Bayer Pharma AG, Germany |
2735.4 |
547.08 |
3282.48 |
4% |
10 |
2745.4 |
549.08 |
3294.48 |
16% |
25 |
2770.4 |
554.08 |
3324.48 |
промяна на обстоятелства решение НСР-1159/13.09.2013 цената е вписана в регистъра на пределните цени с решение НСР-1159/13.09.2013 |
НСР-132/07.06.2013 |
08.07.2013 |
08.07.2013 |
Заличен |
1884 |
| Iopromide |
15104/06,12,2006 |
Ultravist, Solution for injection/infusion, 370mg/ml-500 ml, mg, Pack: 8 |
Schering AG, Германия |
Schering AG, Germany |
3775.73 |
755.15 |
4530.88 |
4% |
10 |
3785.73 |
757.15 |
4542.88 |
16% |
25 |
3810.73 |
762.15 |
4572.88 |
|
КЦ-353/19.12.2008 |
22.01.2009 |
22.01.2009 |
Неактивен |
1884 |
| Iopromide |
15104/06,12,2006 |
Ultravist, Solution for injection/infusion, 370mg/ml-100 ml, mg, Pack: 10 |
Bayer Pharma AG, Германия |
Bayer Pharma AG, Germany; BerliMed S.A., Spain |
538.07 |
107.61 |
645.68 |
4% |
10 |
548.07 |
109.61 |
657.68 |
16% |
25 |
573.07 |
114.61 |
687.68 |
|
НСР-6179/08.05.2015 |
25.05.2015 |
25.05.2015 |
Активен |
3928 |
| Iopromide |
20010204 |
Ultravist, Solution for injection/infusion, 370mg/ml-50 ml, mg, Pack: 10 |
Bayer Pharma AG, Германия |
Bayer Pharma AG, Germany; BerliMed S.A., Spain |
323.1 |
64.62 |
387.72 |
4% |
10 |
333.1 |
66.62 |
399.72 |
16% |
25 |
358.1 |
71.62 |
429.72 |
промяна на обстоятелства НСР-3339/24.04.2014; НСР-5020/17.11.2014 |
НСР-3042/21.03.2014 |
09.04.2014 |
09.04.2014 |
Активен |
2622 |
| Iopromide |
15104/06,12,2006 |
Ultravist, Solution for injection/infusion, 370mg/ml-100 ml, mg, Pack: 10 |
Bayer Pharma AG, Германия |
Bayer Pharma AG, Germany; BerliMed S.A., Spain |
654.32 |
130.86 |
785.18 |
4% |
10 |
664.32 |
132.86 |
797.18 |
16% |
25 |
689.32 |
137.86 |
827.18 |
промяна на обстоятелства НСР-3087/21.03.2014 |
НСР-3011/12.03.2014 |
28.03.2014 |
28.03.2014 |
Неактивен |
3928 |
| Iopromide |
15104/06,12,2006 |
Ultravist, Solution for injection/infusion, 370mg/ml-100 ml, mg, Pack: 10 |
Bayer Schering Pharma AG,, Германия |
Schering AG, Germany |
676.31 |
135.26 |
811.57 |
4% |
10 |
686.31 |
137.26 |
823.57 |
16% |
25 |
711.31 |
142.26 |
853.57 |
|
НСР-134/07.06.2013 |
08.07.2013 |
08.07.2013 |
Неактивен |
3928 |
| Iopromide |
II-12709/29.03.2006 |
Ultravist, Solution for injection/infusion, 370mg/ml-200 ml, mg, Pack: 10 |
Bayer Pharma AG, Германия |
Bayer Pharma AG, Germany; BerliMed S.A., Spain |
1367.71 |
273.54 |
1641.25 |
4% |
10 |
1377.71 |
275.54 |
1653.25 |
16% |
25 |
1402.71 |
280.54 |
1683.25 |
промяна на обстоятелства решение НСР-3088/21.03.2014 |
НСР-133/07.06.2013 |
08.07.2013 |
08.07.2013 |
Активен |
1885 |
| Iopromide |
II-13189/ 04.05.2011 г. |
Ultravist, Solution for injection/infusion, 300mg/ml-50 ml, mg, Pack: 10 |
Bayer Pharma AG, Германия |
Bayer Pharma AG, Germany; BerliMed S.A., Испания |
297.81 |
59.56 |
357.37 |
4% |
10 |
307.81 |
61.56 |
369.37 |
16% |
25 |
332.81 |
66.56 |
399.37 |
Цената е вписана в регистъра на пределните цени с решение НСР-4959/29.10.2014 (в сила от 16.11.2014 ) |
НСР-129/07.06.2013 |
08.07.2013 |
08.07.2013 |
Заличен |
1883 |
| Iopromide |
20010203 |
Ultravist, Solution for injection/infusion, 300mg/ml-20 ml, mg, Pack: 10 |
Bayer Pharma AG, Германия |
Bayer Pharma AG Muellerstrasse 178 13342 Berlin, Germany; BerliMed S.A. Poligono Industrial Santa Rosa, Sector 32 C, 28806 Alcala de Henare, Madrid, Spain |
122.08 |
24.42 |
146.5 |
4% |
4.88 |
126.96 |
25.39 |
152.35 |
16% |
19.53 |
146.49 |
29.3 |
175.79 |
Цената е вписана в регистъра на пределните цени с решение НСР-6260/21.05.2015 (в сила от 16.06.2015 ) |
КЦРР-2946/20.03.2013 |
19.04.2013 |
19.04.2013 |
Заличен |
1787 |
| Iopromide |
20010204 |
Ultravist, Solution for injection/infusion, 370mg/ml-50 ml, mg, Pack: 10 |
Bayer Pharma AG, Германия |
Bayer Pharma AG Muellerstrasse 178 13342 Berlin, Germany; BerliMed S.A. Poligono Industrial Santa Rosa, Sector 32 C, 28806 Alcala de Henare, Madrid, Spain |
346.93 |
69.39 |
416.32 |
4% |
10 |
356.93 |
71.39 |
428.32 |
16% |
25 |
381.93 |
76.39 |
458.32 |
|
КЦРР-2945/20.03.2013 |
19.04.2013 |
19.04.2013 |
Неактивен |
2622 |
| Iopromide |
II-12709/29.03.2006 / 20010204 |
Ultravist, Solution for injection/infusion, 370mg/ml-200 ml, mg, Pack: 10 |
Schering AG, Германия |
Schering AG, Germany |
1480 |
296 |
1776 |
4% |
10 |
1490 |
298 |
1788 |
16% |
25 |
1515 |
303 |
1818 |
|
КЦ-353/19.12.2008 |
22.01.2009 |
22.01.2009 |
Неактивен |
1885 |
| Iopromide |
15104/06,12,2006 |
Ultravist, Solution for injection/infusion, 370mg/ml-50 ml, mg, Pack: 10 |
Schering AG, Германия |
Schering AG, Germany |
482.11 |
96.42 |
578.53 |
4% |
10 |
492.11 |
98.42 |
590.53 |
16% |
25 |
517.11 |
103.42 |
620.53 |
|
КЦ-353/19.12.2008 |
22.01.2009 |
22.01.2009 |
Неактивен |
2622 |
| Iopromide |
15104/06,12,2006 |
Ultravist, Solution for injection/infusion, 370mg/ml-100 ml, mg, Pack: 10 |
Schering AG, Германия |
Schering AG, Germany |
952.49 |
190.5 |
1142.99 |
4% |
10 |
962.49 |
192.5 |
1154.99 |
16% |
25 |
987.49 |
197.5 |
1184.99 |
|
КЦ-353/19.12.2008 |
22.01.2009 |
22.01.2009 |
Неактивен |
3928 |
| Iopromide |
15103/06,12,2006 |
Ultravist, Solution for injection/infusion, 300mg/ml-20 ml, mg, Pack: 10 |
Schering AG, Германия |
Schering AG, Germany |
236.56 |
47.31 |
283.87 |
4% |
9.46 |
246.02 |
49.2 |
295.22 |
16% |
25 |
271.02 |
54.2 |
325.22 |
|
КЦ-353/19.12.2008 |
22.01.2009 |
22.01.2009 |
Неактивен |
1787 |
| Iopromide |
15103/06,12,2006 |
Ultravist, Solution for injection/infusion, 300mg/ml-50 ml, mg, Pack: 10 |
Schering AG, Германия |
Schering AG, Germany |
460.6 |
92.12 |
552.72 |
4% |
10 |
470.6 |
94.12 |
564.72 |
16% |
25 |
495.6 |
99.12 |
594.72 |
|
КЦ-353/19.12.2008 |
22.01.2009 |
22.01.2009 |
Неактивен |
1883 |
| Albumin |
II-3407/05,11,2008 |
UMAN ALBUMIN 20%, Solution for infusion, 50 ml, ml, Pack: 1 |
Kedrion S.p.A., Италия |
Kedrion S.p.A., Italy |
48.9 |
9.78 |
58.68 |
4% |
1.96 |
50.86 |
10.17 |
61.03 |
16% |
7.82 |
58.68 |
11.74 |
70.42 |
|
НСР-6507/18.06.2015 |
04.07.2015 |
04.07.2015 |
Активен |
535 |
| Albumin |
II-3407/05,11,2008 |
UMAN ALBUMIN 20%, Solution for infusion, 100 ml, ml, Pack: 1 |
Kedrion S.p.A., Италия |
Kedrion S.p.A., Italy |
97.79 |
19.56 |
117.35 |
4% |
3.91 |
101.7 |
20.34 |
122.04 |
16% |
15.65 |
117.35 |
23.47 |
140.82 |
|
НСР-6506/18.06.2015 |
04.07.2015 |
04.07.2015 |
Активен |
534 |
| Albumin |
II-3407/05,11,2008 |
UMAN ALBUMIN 20%, Solution for infusion, 50 ml, ml, Pack: 1 |
Kedrion S.p.A., Италия |
Kedrion S.p.A., Italy |
50.46 |
10.09 |
60.55 |
4% |
2.02 |
52.48 |
10.5 |
62.98 |
16% |
8.07 |
60.55 |
12.11 |
72.66 |
|
КЦ-562/20.02.2009 |
11.03.2009 |
11.03.2009 |
Неактивен |
535 |
| Albumin |
II-3407/05,11,2008 |
UMAN ALBUMIN 20%, Solution for infusion, 100 ml, ml, Pack: 1 |
Kedrion S.p.A., Италия |
Kedrion S.p.A., Italy |
100.26 |
20.05 |
120.31 |
4% |
4.01 |
104.27 |
20.85 |
125.12 |
16% |
16.04 |
120.31 |
24.06 |
144.37 |
|
КЦ-562/20.02.2009 |
11.03.2009 |
11.03.2009 |
Неактивен |
534 |
| Coagulation factor IX, II, VII and X in combination |
20040521 |
Uman complex powd. Inf. Vial 500 IU + solv. Vial 20 ml + inf. Set, Solution for infusion, 500, IU, Pack: 1 |
Kedrion S.p.A., Италия |
Kedrion S.p.A., Italy |
246.65 |
49.33 |
295.98 |
4% |
9.87 |
256.52 |
51.3 |
307.82 |
16% |
25 |
281.52 |
56.3 |
337.82 |
отхвърлена жалба от Комисия по прозрачност с Решение КП-4/15.01.2015 ; промяна на обстоятелства НСР-5645/13.02.2015 ; цената е вписана в регистъра на пределените цени НСР-5645/13.02.2015 (допуска предварително изпълнение) |
НСР-1935/27.11.2013 |
02.02.2015 |
02.02.2015 |
Заличен |
3500 |